Ono Pharmaceutical Co., Ltd. (Osaka, Japan; CEO: Sagara line; ‘Ono Pharmaceutical’) is a subsidiary of Ono Pharmaceutical Oncology, Immunology, Neurological Research Foundation, General Incorporated Foundation (“New Foundation”) for the purpose of contributing to academia January 26, 2023 And today, we have resolved to contribute the necessary funds to start the research grant project.
Ono Pharmaceutical has positioned the creation of innovative pharmaceuticals as one of the important issues to be addressed under its corporate philosophy of “Dedicated to the fight against disease and pain,” and positions the areas of cancer, immunology, and neurology as priority areas. increase. Research and Development. Ono Pharmaceutical continues to take on the challenge of discovering and developing more unique and innovative pharmaceuticals by actively promoting open innovation, which is one of its strengths.
new foundation We support basic research in the medical and pharmaceutical fields with the aim of “contributing to the health of people around the world by supporting researchers who bring about cutting-edge science and breakthrough research results.” increase. The new research results obtained from these activities will contribute to the health of people around the world in line with our corporate philosophy. We believe that these activities will contribute to the sustainable growth and improvement of our corporate value from the medium- to long-term perspective of contributing to the health of people around the world through the progress of research in the pharmaceutical and drug discovery fields.
contact:
Email Address: Relations@ono-pharma.com
(C) 2023 Electronic News Publishing, source ENP Newswire
